Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials
===============================================================================================================================================================

* Espen Basmo Ellingsen
* Elin Aamdal
* Tormod Guren
* Wolfgang Lilleby
* Paal F Brunsvig
* Sara M Mangsbo
* Steinar Aamdal
* Eivind Hovig
* Nadia Mensali
* Gustav Gaudernack
* Else Marit Inderberg